Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Neuropharmacology. 2015 Jul 31;99:337–346. doi: 10.1016/j.neuropharm.2015.07.036

Table 1.

IOP measurements obtained under different experimental conditions. IOP measurements were obtained using a Tonopen according to the procedure outlined by Iwamoto et al. (2013).

Experimental
Conditions:
Mean IOP measurement
from each animal (mmHg)
Average IOP for each
experimental condition
Control untreated
(N=20)
13.2; 11.8; 12.7; 13.5; 11.6;
12.8; 12.9; 13.3; 12.8; 14.1;
12.8; 12.7; 13.6; 15.1; 14.2;
13.7; 14.3; 12.8; 11.7; 11.9
13.08 +/− 0.20 mmHg
4 weeks after hypertonic
saline injection (N=20)
19.5; 22.5; 23.6; 18.9; 23.5;
25.2; 23.4; 22.5; 26.2; 18.7;
19.8; 18.7; 18.5; 22.9; 21.3;
20.5; 21.3; 24.5; 25.6; 24.2
22.06 +/− 0.70 mm Hg
4 weeks after hypertonic
saline injection and
2 mM PNU (N=12)
21.3; 22.5; 20.7; 21.6; 19.8;
18.6; 18.9; 22.8; 23.3; 21.5;
20.9; 22.5
21.2 +/− 0.42 mm Hg
4 weeks after PNU only
2 mM PNU (N=4)
14.8; 13.9; 14.2; 12.8 13.93 +/− 0.36 mm Hg